Author: Tokio X'press
Opivibo, the first cancer immunotherapy drug in China, approved by the Chinese National Drug Administration and Supervision Agency for indications of treatment non-small cell lung cancer with history
ABB and Kawasaki create world’s first common interface for collaborative robots
Number of foreign visitors to Japan announced estimates for May 2018 16.6% increase from the same month of the previous year 2,675 thousand people
World’s Most Innovative Companies – 2018 (Forbes)